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Abstract 
Simultaneous determination of Furosemide, Carbamazepine, Diazepam, and Carvedilol in bulk and 
pharmaceutical formulation using the partial least squares regression (PLS-1 and PLS-2) is described in this study. 
The two methods were successfully applied to estimate the four drugs in their quaternary mixture using UV spectral 
data of 84synthetic mixtures in the range of 200-350nm with the intervals ∆λ=0.5nm. The linear concentration 
range were 1-20 µg.mL-1 for all, with correlation coefficient (R2) and root mean squares error for the calibration 
(RMSE) for FURO, CARB, DIAZ, and CARV were 0.9996, 0.9998, 0.9997, 0.9997, and 0.1128, 0.1292, 
0.1868,0.1562 respectively for PLS-1, and for PLS-2 were 0.9995, 0.9999, 0.9997, 0.9998, and 0.1127, 0.1205, 
0.1691, and 0.1686 respectively. Satisfactory results were achieved with applying PLS-1 and PLS-2 in the 
determination of the cited drugs in their pharmaceutical formulations and a good agreement was found between 
the proposed methods.      
Keywords: PLS, spectrophotometry, furosemide, carbamazepine, diazepam, and carvedilol 
 
1. Introduction 
Furosemide (FURO), fig.1a; is an anthranilic acid derivative, chemically known as 4-Chloro-2-[(furan-2-ylmethyl) 
amino]-5-sulfamoylbenzoic acid (British Pharmacopoeia 2013). Furosemide is a potent diuretic drug commonly 
used in adults, children, and infants for the management of excessive fluid accumulation and edema caused by 
congestive heart failure, renal disease and cirrhosis of the liver. In adults, oral FURO may be used alone or in 
combination with different antihypertensive agents for the treatment of hypertension (Şimşek et al. 2012). 
Carbamazepine (CARB), fig.1b; is a tricyclic highly lipophilic neutral compound, chemically 5H-
Dibenzo [b, f] azepine-5-carboxamide (British Pharmacopoeia 2013). Extensively it is used as antiepileptic, mood 
stabilizing, and in treatment of bipolar affective disorder like restless leg syndrome, resistant schizophrenia, 
psychotic behavior associated with dementia, post-traumatic stress disorders, and ethanol withdrawal (Leikin & 
Paloucek 2008). 
Diazepam (DIAZ), fig.1c; is a benzodiazepine derivative drug, chemically defined as 7-Chloro-1-
methyl-5-phenyl 1, 3 -dihydro-2H-1,4 -benzodiazepin-2-one (British Pharmacopoeia 2013), commonly used in 
anxiety disorders management, skeletal muscle relaxant, sleep disturbance, seizures including status epilepticus, 
and in treatment of convulsive disorders (Riss et al. 2008).  
Carvedilol (CARV), fig.1d; is a racemic lipophilic aryoxypropanolamine, chemically (2RS)-1-(9H-
Carbazol-4-yloxy)-3-[[2-(2-methoxyphenoxy) ethyl] amino] propan-2-ol (British Pharmacopoeia 2013). 
Carvedilol belongs to a medicines group called β- adrenoceptor antagonist agents which indicated for the treatment 
of hypertension, angina pectoris, arteriolar vasodilator, and  mild or moderate heart failure of ischemic or 
cardiomyopathic . As compared with other beta-blockers, carvedilol has minimal inverse agonist activity and the 
morbidity from congestive heart failure has been decreased with its use (Packer et al. 2002). 
 
Figure 1. Chemical structures of FURO (a), CARB (b), DIAZ (c), and CARV (d). 
Literature survey reveals several conventional analytical techniques including spectrophotometry, 
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HPLC, flow injection analysis, FT-IR, spectofluorimetry voltammetry, hyphenated techniques such as GC-MS, 
HPLC-MS and so on for individual or simultaneous quantification of FURO (Semaan et al. 2005, Zaporozhets et 
al. 2012, Gallignania et al. 2014, Santini  et al. 2009, Pate & Solanki 2012 and Ram et al. 2012), CARB (Jayanna 
et al. 2014, Sultana et al. 2013, Zhang et al. 2009, Hoehn 2014, Pan et al. 2014 and Kumar & Umamaheswari 
2011), DIAZ (Mohamed et al. 2014, Sruthi et al. 2013, Liawruangrath  et al. 2006, Cordero & Paterson 2007, 
Moros  et al. 2007, Metrohm 250/1e and Shweta et al. 2013), and CARV (Shariti-Rad et al. 2014, Elezovi  et al. 
2015, Silva et al. 2008, Yilmaz & Arslan 2011, Jagannathan et al. 2010 and Yilmaz & Ekinci 2011) in pure form, 
pharmaceutical formulation, and  biological fluids. 
To our knowledge, the published literatures did not cover the simultaneous analysis of the quaternary 
mixture of FURO, CARB, DIAZ, and CARV in API and pharmaceutical formulation, however there is a few 
methods (Patil et al. 2012, Zhang et al. 2011 and Netherton 2011) were reported for the simultaneous determination 
of two or three of the proposed drugs. 
The spectrophotometric study of several species in their mixture to discriminate between in them 
depending on differences in their spectral properties is often suffer from having overlapping spectral characteristics. 
Recently, such studies in which heavily overlapping responses of the studied components are present were possible 
to be carry out relying on chemometrics multivariate procedures (Niazi & Yazdanipour 2007). 
Several chemometric techniques based on artificial intelligence and factor analysis; including design of 
experimental (DOE), classical least square (CLS), principle component regression (PCR), artificial neural network 
(ANN), and partial least squares (PLS-1 and PLS-2 models) have been applied increasingly for multicomponent 
investigations (Solanki et al. 2014, Karaoglan et al. 2007, Torrecilla et al. 2008, Nguyen & Rocke 2002 and Dinc 
et al. 2006). 
PLS is a linear regression method that forms components (factors, or latent variables) as new 
independent variables (explanatory variables, or predictors) in a regression model. In PLS two matrices are worked: 
X and Y, where generally X matrix (its dimension N x K) contains the independent variables (predictors) and Y 
matrix (its dimension N x M) contains dependent variables (response) (Figure 2) (Eriksson et al. 20130).  
 
Figure 2. Schematic representation of PLS 
In analytical chemistry, where PLS is mainly used in multivariate calibration, X matrix contains the 
digitized spectral data (N) at wavelengths (K) while Y matrix contains the analyte concentrations of N training set 
samples. 
The PLS regression can be considered as involving of outer relations, for X and Y matrices individually, 
(equations 1 and 2 respectively) and an inner relation links both matrices together (equation 3). 
X = TP´ + E               (1) 
Y = UC´ + F              (2) 
U = BT + H               (3) 
Where T and U are score matrices, P´ and C´ are loading matrices, E and F are matrices residual of X 
and Y block respectively (Geladi & Kowalski 1986).     
Two PLS models of calculations are available, in the PLS1 regression (PLS univariate regression), there 
is only one dependent variable, whilst in the PLS2 regression (PLS multivariate regression) there are several 
dependent variables. In light of the fact that both PLS-1 and PLS-2 enables quick and simultaneous analysis of 
each species in the mixture, with slightest sample pre-treatments or need for pre-separation (Steele 1989 and Geladi 
& Kowalski 1986), therefore we have applied both of them in this study.   
 
2. Experimental 
2.1 Apparatus 
A Cecil CE7200 UV-Visible double beam spectrophotometer (Cambridge-England) equipped with 10 mm quartz 
cell was used. The Cecil Instrument-DataStream Software Version: 5.1 was used for all data acquisition. 
  
2.2 Software 
A Simplex Lattice Mixture Design (create by JMP® 11.0.0 SAS Institute Inc.) was used to prepare a set of 
calibration mixtures for the simultaneous determination of FURO, CARB, DIAZ, and CARV, while PLS analysis 
which were carried out by using OriginPro software (internal version 9.2). 
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2.3 Chemicals 
The standard grade powder (furosemide, carbamazepine, diazepam, and carvedilol) used in this work received in 
pure form (99.99%) as a gift from the State Company for Drug Industries and Medical Appliances Samara-Iraq 
(SDI). Methanol (99.9 %) for HPLC (Sigma Aldrich, Germany).  
Pharmaceutical formulations assayed in this study were procured from local pharmacies; Lasix 40 mg / 
table (SWI, France), Tegretol® 200 mg / tablet (NOVARTIS, Switzerland), VALIAPAM 2 mg / tablet (SDI, Iraq), 
and Carvidol® 25 mg /tablet (Pharma International, India).  
 
2.4 Standard Drugs Solution 
Standard solutions (1000 μg.mL-1) of FURO, CARB, DIAZ, and CARV (SDI) were prepared by dissolution in 
methanol. All chemicals and solvents used were of analytical reagent grade. 
 
2.5 Procedure 
2.5.1 Procedure for resolving quaternary mixtures 
In a 5-ml volumetric flask aliquot of mixture sample solution containing between 5-100 μg of each of the studied 
drugs was introduced and diluted with methanol. The calibration set composed of eighty-four mixtures 
combination prepared according to optimal mixture design (Simplex Lattice).  
The spectrum for each of the 84-prepared mixtures was recorded in wavelength range 200-350 nm, with 
a scan speed of 10 nm.sec-1, averaging of 1.0 nm, bandwidth of 1.8 nm, and data interval of 0.5 nm against solvent 
blank. The optimized conditions used for calibration matrix was applied to analyze the problem samples and 
calculate the concentrations for the four components in the mixture. 
2.5.2 Analysis of FURO, CARB, DIAZ, and CARV in commercial formulations 
Ten tablets of each pharmaceutical product were separately weighed to an average weight. After crushing, mixing 
and homogenizing, a portion equivalent to 0.0399 gm, 0.0128 gm, 0.6014 gm, and 0.1522 gm for Lasix®, Tegretol®, 
VALIAPAM, and Carvidol® respectively were weighed, dissolved in about 40 mL of methanol and sonicated for 
at least 10 min with intermittent shaking. The contents of each were transferred quantitatively into a separate 10 
mL volumetric flask, shaken well and diluted to mark with methanol to get 1000 µg.mL-1. The solutions were 
filtered through Whatman No.41 filter paper and stored as the standard stock solutions for further dilution in 
subsequent use. Aliquots of the standard stock solution were placed in a 5-ml volumetric flask, and then analyzed 
as described above.  
           
3. Results and discussion 
The absorption spectra of FURO, CARB, DIAZ, and CARV were recorded in the wavelength range of 200-350 
nm. The linearity of the maximal signals was examined to select an adequate concentration range (for each 
individual compound) suitable for spectrophotometric measurements. It was found that linear concentration range 
of 1.0-20.0 μg.mL-1, as absorbance versus drugs concentrations, at 233 nm, 228.5 nm, 215.0 nm, and 242.5 nm for 
FURO, DIAZ, CARB, and CARV respectively was obtained and statistically evaluated by linear regression.  
On the other hand, Figure 3 shows that resolving of such mixture cannot be carried out by univariate 
analysis methods snice their spectra of seems to be strongly overlapped. Therefore, simultaneous multicomponent 
analysis of UV-VIS measurements via partial least squares (PLS) was applied for this purpose. 
 
Figure 3. Normal mode spectrum of 10 μg.mL-1 of FURO, CARB, DIAZ, and CARV against their solvent blanks 
(recorded with scan speed of 10 nm.sec-1, averaging of 1.0 nm, bandwidth of 1.8 nm, and data interval of 0.5 nm). 
Training set was obtained from the spectrophotometric data by a careful UV-measurements on a set of 
known samples, composing of 84 mixtures. The composition of samples to be determined have been selected 
according to Simplex Lattice Mixture Design in order to span all dimensions without correlation between different 
calibration samples since collinear components in the training set data tends to cause under fitting in the PLS 
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models (Zolgharnein et al. 2015). 
This set was used to establish PLS-1 and PLS-2 modes of calibrations after arranging the data as matrix, 
which organized into pairs i.e. each absorbance matrix is paired with its corresponding concentration matrix. In 
the first case, PLS-2, the concentrations of all components in the quaternary mixture were correlated to the values 
of the measured absorbance, while in PLS-1 the concentration of each drug in the mixture was used to build up 
the models. 
The spectral information in the range of 200-350 nm (301 experimental points per spectrum) was used 
for the calibration. The data were feed to OriginPro 2015 software, after arranging them as row absorbance matrix 
paired with their corresponding concentration matrix, to build up PLS-1 and PLS-2 regression modes. 
 
3.1 Selection of the optimum number of factors for the partial least-squares methods 
Cross-validation technique was used to select the smallest model with fewest numbers of factors in the PLS 
algorithm. This was carried out by randomly leaving out one sample at a time and letting the software to predict 
the value of residual error sum of squares (PRESS = ) and use it as an indicator for appropriateness 
of models  (Afkhami & Sarlak 2005). Figure 4 shows the plot of PRESS against the number of factors for PLS-2 
and PLS-1 model for determination of drugs in their pure forms. 
   
   
 
Figure 4. Plots of Root Mean PRESS against number of factors for eighty-four CARV, DIAZ, CARB, and FURO 
mixtures for (A) PLS-2 model, (B) PLS-1 model for CARV, (C) PLS-1 model (D) for DIAZ, and (E) for CARV 
PLS-1 model. 
 
3.2 Statistical parameters for the optimized models 
The predictive capabilities PLS-1 and PLS-2 models were examined for simultaneous determination of FURO, 
DIAZ, CARB, and CARV in each mixtures of the train set. Moreover, the prediction error of a single component 
in the mixture contain the four drugs samples (N) and total prediction error of forty sample mixtures (M) were 
calculated as the single and total relative standard error (R.S.E %) of the prediction concentration  (Niazi & 
Yazdanipour 2007). 
R.S.E.(%) single =  × 100 , 
R.S.E.(%) total =  × 100. 
The developed PLS-1 and PLS-2 models were validated by testing their predictive abilities for simultaneous 
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determination of CARV, DIAZ, CARB, and FURO in twenty quaternary synthetic mixtures set. Tables 1 and 2 
show the predicted results and other statistical parameters. 
Table 1. Composition of synthetic samples, their predictions by PLS-1 model and statistical parameters for the 
system. 
        Mixture (μg.mL-1)      .      Prediction (μg.mL-1)     .                   Recovery %         .   
CARV DIAZ CARB FURO CARV DIAZ CARB FURO CARV DIAZ CARB FURO 
3.3 13.3 0.0 3.3 3.2026 13.13663 0.07597 3.18185 97.0485 98.7717 ---- 96.4197 
10.0 0.0 0.0 10.0 10.12346 0.12174 0.00193 10.15812 101.2346 ---- ---- 101.5812 
6.7 0.0 13.3 0.0 6.64987 0.08006 13.35623 ---- 99.2518 ---- 100.4228 ---- 
6.7 13.3 0.0 0.0 6.72821 12.93153 0.19586 ---- 100.4210 97.2295 ---- ---- 
3.3 0.0 13.3 3.3 3.31485 0.04508 13.32951 3.34501 100.4500 ---- 100.2219 101.3639 
16.7 3.3 0.0 0.0 17.00413 3.12232 ---- 0.2181 101.8211 94.6158 ---- ---- 
13.3 3.3 0.0 3.3 13.32955 3.33491 0.07932 3.35378 100.2222 101.0579 ---- 101.6297 
3.3 6.7 6.7 3.3 3.21623 6.53646 6.92744 3.22136 97.4615 97.5591 103.3946 97.6170 
6.7 0.0 3.3 10.0 6.78976 0.08845 3.3884 10.07961 101.3397 ---- 102.6788 100.7961 
0.0 10.0 10.0 0.0 ---- 9.67557 10.21714 ---- ---- 96.7557 102.1714 ---- 
0.0 3.3 3.3 13.3 0.02684 3.31828 3.47743 13.45101 ---- 100.5539 105.3767 101.1354 
0.0 0.0 10.0 10.0 0.07424 ---- 9.99918 10.12232 ---- ---- 99.9918 101.2232 
0.0 13.3 6.7 0.0 ---- 13.18113 6.76265 ---- ---- 99.1062 100.9351 ---- 
0.0 0.0 20.0 0.0 ---- 0.12764 19.96457 -0.14006 ---- ---- 99.8229 ---- 
0.0 10.0 0.0 10.0 ---- 10.06795 0.01335 9.80244 ---- 100.6795 ---- 98.0244 
0.0 20.0 0.0 0.0 ---- 19.83869 ---- ---- ---- 99.1935 ---- ---- 
10.0 0.0 10.0 0.0 10.36272 ---- 9.8465 ---- 103.6272 ---- 98.4650 ---- 
0.0 0.0 13.3 6.7 0.03046 ---- 13.28889 6.83778 ---- ---- 99.9165 102.0564 
3.3 10.0 0.0 6.7 3.28586 9.87426 0.0476 6.68036 99.5715 98.7426 ---- 99.7069 
0.0 6.7 10.0 3.3 ---- 6.52563 10.17081 3.30186 ---- 97.3975 101.7081 100.0564 
Mean  
recovery 
    
  
    
100.2227 98.4719 101.2588 100.1342 
RSE (%)  
single 
    
  
    
2.4059 1.8988 1.3259 2.1000 
RSE (%) 
 total 
       
1.8828 
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Table 2. Composition of synthetic samples, their predictions by PLS-2 model and statistical parameters for the system. 
        Mixture (μg.mL-1)      .      Prediction (μg.mL-1)     .                   Recovery %         .   
CARV DIAZ CARB FURO CARV DIAZ CARB FURO CARV DIAZ CARB FURO 
3.3 13.3 0.0 3.3 3.3481 13.1693 0.1820 3.13599 101.4576 99.0173 ---- 95.0300 
10.0 0.0 0.0 10.0 10.2570 0.0835 0.0261 10.0956 102.5700 ---- ---- 100.9560 
6.7 0.0 13.3 0.0 6.5809 0.0699 13.3650 0.00675 98.2224 ---- 100.4887 ---- 
6.7 13.3 0.0 0.0 6.7602 12.9805 0.1865 ---- 100.8985 97.5977 ---- ---- 
3.3 0.0 13.3 3.3 3.3314 0.0086 13.3641 3.37328 100.9515 ---- 100.4820 102.2206 
16.7 3.3 0.0 0.0 17.0327 3.1270 0.1241 0.24191 101.9922 94.7576 ---- ---- 
13.3 3.3 0.0 3.3 13.3979 3.3460 0.0817 3.34953 100.7361 101.3939 ---- 101.5009 
3.3 6.7 6.7 3.3 3.3528 6.5393 6.9267 3.1975 101.6000 97.6015 103.3836 96.8939 
6.7 0.0 3.3 10.0 6.8766 0.0705 3.3952 10.01743 102.6358 ---- 102.8848 100.1743 
0.0 10.0 10.0 0.0 ---- 9.7072 10.1334 ---- ---- 97.0720 101.3340 ---- 
0.0 3.3 3.3 13.3 0.0248 3.3474 3.4425 13.4353 ---- 101.4364 104.3182 101.0173 
0.0 0.0 10.0 10.0 0.0861 ---- 10.0766 10.11617 ---- ---- 100.7660 101.1617 
0.0 13.3 6.7 0.0 ---- 13.1707 6.8976 ---- ---- 99.0278 102.9493 ---- 
0.0 0.0 20.0 0.0 ---- 0.1239 20.0435 ---- ---- ---- 100.2175 ---- 
0.0 10.0 0.0 10.0 ---- 10.1378 0.0041 9.81082 ---- 101.3780 ---- 98.1082 
0.0 20.0 0.0 0.0 ---- 19.9132 0.1409 ---- ---- 99.5660 ---- ---- 
10.0 0.0 10.0 0.0 10.2569 ---- 9.9736 0.02623 102.5690 ---- 99.7360 ---- 
0.0 0.0 13.3 6.7 0.0631 ---- 13.3380 6.84287 ---- ---- 100.2857 102.1324 
3.3 10.0 0.0 6.7 3.3726 9.8785 0.0820 6.61038 102.2000 98.7850 ---- 98.6624 
0.0 6.7 10.0 3.3 0.0290 6.5577 10.1353 3.25968 ---- 97.8761 101.3530 98.7782 
Mean  
recovery 
    
  
   
 101.4393 98.7924 101.5165 99.7197 
RSE (%)  
single 
    
  
   
 2.4413 1.7160 1.4215 2.1113 
RSE (%) 
 total 
       
1.8620 
 
The mean squares (MSE = ), the root mean squares error (RMSE = ), which is an 
indication of the average error in the analysis, for each component, was determined for the calibration (RMSEC), 
where  !  and  "!  are  the known and predicted analyte concentrations, respectively, and N is the number of 
mixtures in the data set (Jahan & Ghasemi 2010),. Moreover, mean standard deviation of the entire calibrated 
mixture solutions and correlation coefficient (r) between the used and calculated concentration in the synthetic 
mixture are given in Tables 3 and 4 for PLS-1 and PLS-2 models respectively.  
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Table 3. Goodness of fit statistics for synthetic samples set analyses by PLS-1. 
          Parameter          . 
Variable  
CARV DIAZ CARB FURO 
Observations 11 12 12 12 
Sum of weights 11 12 12 12 
Correlation coefficient (r) 0.9997 0.9997 0.9998 0.9996 
Std. deviation 0.1493 0.1314 0.1140 0.1141 
MSE  0.0244 0.0349 0.0167 0.0127 
RMSEC 0.1562 0.1868 0.1292 0.1128 
Table 4. Goodness of fit statistics for synthetic samples set analyses by PLS-2. 
          Parameter          . 
Variable  
CARV DIAZ CARB FURO 
Observations 11 12 12 12 
Sum of weights 11 12 12 12 
Correlation coefficient (r) 0.9998 0.9997 0.9999 0.9995 
Std. deviation 0.1291 0.1338 0.0712 0.1176 
MSE  0.0284 0.0286 0.0145 0.0127 
RMSEC 0.1686 0.1691 0.1205 0.1127 
The predicted concentrations of synthetic mixture samples via PLS-1 and PLS2 models for the four 
drugs in their quaternary synthetic mixtures were plotted versus the true concentrations, Figures 5 and 6. The plots 
show a large agreement in the results. 
 
 
Figure 5. Plots of PLS-1 predicated vs true drugs concentrations in synthetic quaternary mixtures; (A) CARV, (B) 
DIAZ, (C) CARB, and (D) FURO. 
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Figure 6. Plots of PLS-2 predicated vs true drugs concentrations in synthetic quaternary mixtures; (A) CARV, (B) DIAZ, 
(C) CARB, and (D) FURO. 
 
Figures 7 and 8 represent the plots of the standardized concentration residuals vs the predicted 
concentrations of the tested mixtures. The residuals for CARV, DIAZ, CARB, and FURO in all samples appear to 
be randomly distributed around zero. 
 
Figure 7.  Plots of standardized concentration residuals vs predicted drugs concentrations for the quaternary synthetic 
mixture samples, by PLS-1 model. 
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Figure 8.  Plots of standardized concentration residuals vs predicted drugs concentrations for the quaternary synthetic 
mixture samples, by PLS-2 model. 
 
3.3 Accuracy and Precision 
Two different levels of concentration of each drug were used to check the accuracies and precisions of the two 
proposed PLS models in the simultaneously determination of CARV, DIAZ, CARB, and FURO in quaternary 
synthetic mixtures. Results are depicted in Table 5 indicate excellent accuracy and precision values of the method at 
each concentration level. 
Table 5. Accuracy and precision of the proposed method. 
  (μg.mL-1)    
Drug Model Taken                         Found                           .  Mean RE % RSD% 
CARV 
PLS-1 
3.3 
3.2026 3.3149 3.2162 3.2859 3.2549 -1.3671 1.6624 
PLS-2 3.3481 3.3314 3.3528 3.3726 3.3512 1.5523 0.5059 
PLS-1 
6.7 
6.6499 6.7282 6.7898 --- 6.7226 0.3378 1.0430 
PLS-2 6.5809 6.7602 6.8766 --- 6.7392 0.5856 2.2104 
DIAZ 
PLS-1 
3.3 
3.1223 3.3349 3.3183 --- 3.2585 -1.2575 3.6284 
PLS-2 3.1270 3.3460 3.3474 --- 3.2735 -0.8040 3.8750 
PLS-1 
13.3 
13.1366 12.9315 13.1811 --- 13.0831 -1.6311 1.0176 
PLS-2 13.1693 12.9805 13.1707 --- 13.1068 -1.4524 0.8348 
CARB 
PLS-1 
10.0 
10.2171 9.99918 9.8465 10.17081 10.0584 0.5841 1.6857 
PLS-2 10.1334 10.0766 9.9736 10.1353 10.0797 0.7972 0.7521 
PLS-1 
13.3 
13.3562 13.32951 13.28889 --- 13.3249 0.1870 0.2545 
PLS-2 13.3650 13.3641 13.338 --- 13.3557 0.4188 0.1148 
FURO 
PLS-1 
3.3 
3.1819 3.3450 3.3538 3.2214 3.2755 -0.7424 2.6534 
PLS-2 3.1360 3.3733 3.3495 3.1975 3.2641 -1.0886 3.5405 
PLS-1 
10.0 
10.1581 10.0796 10.1223 9.8024 10.0406 0.4062 1.6134 
PLS-2 10.0956 10.0174 10.1162 9.8108 10.0100 0.1000 1.3930 
 
3.4 Application 
The proposed methods were successfully applied to several real samples for determination of these drugs in 
tablet formulations, five replicate measurements were made and the results are shown in Tables 6. The results 
show that there is a respectable agreement between the calculated values and the label claims indicates the 
applicability of the proposed PLS models for the simultaneous determination of CARV, DIAZ, CARB, and 
FURO in real sample. 
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Tables 6. Application of the PLS methods to the CARV, DIAZ, CARB, and FURO concentration 
measurements in drugs tablet formulation samples. 
Sample 
Weight  (mg/tablet) 
Mean 
Recovery 
% 
C.V. 
% Labeled Found 
PLS-1 
Carvidol® 25 26.164 26.315 26.123 25.909 25.418 25.986 103.943 1.344 
Valiapam 2 1.995 2.000 1.899 1.911 1.888 1.939 96.943 2.809 
Tegretol® 200 188.682 195.633 191.006 191.290 197.030 192.728 96.364 1.804 
Lasix 40 42.397 41.303 39.755 39.927 39.744 40.625 101.563 2.918 
PLS-2 
Carvidol® 25 26.290 26.297 26.035 25.772 25.402 25.959 103.836 1.460 
Valiapam 2 1.967 1.964 1.870 1.862 1.836 1.900 94.989 3.225 
Tegretol® 200 184.976 193.910 189.946 190.664 196.109 191.121 95.560 2.220 
Lasix 40 40.495 40.362 39.294 39.826 40.912 40.178 100.445 1.563 
 
4. Conclusion 
The present work proved that UV spectrophotometric-assisted chemometric methods (PLS-1 and PLS-2) can be 
successfully used in the resolving of multicomponent mixtures without previous treatment. The obtained results 
of analysis of correlation parameters for the cited drugs were shown high precision that allow simple, rapid, 
economical, and accurate simultaneous determination of the cited drugs in their pure form and commercial dosage 
preparations. 
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